Factors Influencing Drug Absorption: Presystemic Elimination

The first-pass effect occurs when oral drugs are absorbed from the intestines into the hepatic portal vein and pass through the liver before entering systemic circulation. During this pre-systemic elimination, drugs are metabolized or excreted into bile, decreasing their bioavailability—the accessible drug fraction available for therapeutic action. This process significantly reduces the amount of active drug reaching the systemic circulation.

The liver extraction ratio (ER) measures the fraction of drug removed during its first pass through the liver, calculated from drug concentrations entering and exiting the hepatic tissue. ER depends on hepatic blood clearance and flow rates. Drugs with high extraction ratios undergo extensive pre-systemic metabolism, resulting in poor oral bioavailability and requiring higher doses to achieve therapeutic response.

Drugs with low extraction ratios, such as theophylline, undergo minimal pre-systemic elimination and are completely absorbed following oral administration. Conversely, drugs with high extraction ratios like verapamil, propranolol, and nitroglycerin are extensively metabolized pre-systemically, leading to poor bioavailability. High-extraction drugs require substantially higher oral doses or alternative administration routes to achieve adequate therapeutic effects.

Approximately 90% of oral nitroglycerin undergoes pre-systemic elimination in the liver, resulting in severely reduced bioavailability. Sublingual administration bypasses the hepatic portal system and pre-systemic metabolism, allowing the drug to enter systemic circulation directly. This alternative route preserves nitroglycerin's potency and therapeutic efficacy at lower doses compared to oral administration.

Alternative routes such as sublingual and transdermal administration deliver drugs directly to systemic circulation, circumventing pre-systemic elimination. These non-oral extravascular drug absorption routes are particularly valuable for drugs with high extraction ratios that undergo extensive hepatic metabolism. By avoiding the hepatic portal system, these routes improve bioavailability and reduce required dose amounts.

The liver extraction ratio depends directly on hepatic blood clearance and circulatory flow dynamics through the liver. Changes in these parameters alter the drug's bioavailability by affecting how much drug is metabolized or excreted during the first pass. Variations in hepatic blood flow and clearance capacity can significantly impact the extent of pre-systemic elimination and the amount of active drug reaching systemic circulation.

Drugs with high extraction ratios undergo extensive pre-systemic metabolism, meaning a large fraction is removed during the first pass through the liver before reaching systemic circulation. To achieve adequate therapeutic response, higher oral doses must be administered to compensate for the substantial loss during hepatic metabolism. This dose adjustment ensures sufficient active drug reaches the systemic circulation for therapeutic efficacy.